Results 91 to 100 of about 1,983,235 (163)

Anti-gal and anti-neu5gc responses in non-immunosuppressed patients following treatment with anti-thymocyte globulin

open access: yes, 2017
International audienceBackground Polyclonal antihuman thymocyte rabbit IgGs (antithymocyte globulin [ATG]) are popular immunosuppressive drugs used to prevent or treat organ or bone-marrow allograft rejection, graft versus host disease, and autoimmune ...
Nicot, Arnaud   +11 more
core   +2 more sources

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

open access: yes, 2020
International audienceMeasurable residual disease (MRD) status pre-allogeneic hematopoietic cell transplantation (allo-HCT) has been shown to predict transplant outcomes.
Jean-Yves Cahn   +29 more
core   +1 more source

Immunomodulation with rabbit anti-thymocyte globulin in solid organ transplantation

open access: yes, 2015
: Rabbit anti-thymocyte globulin's manifold mechanisms of action may be attribuited to its polyclonal nature. Its T-cell depleting effect on lymphoid cells is well established: Occurring in the blood and secondary lymphoid tissues, depletion proceeds ...
Paulli Marco   +3 more
core   +1 more source

Acute Elevation of Liver Enzymes Following Anti-thymocyte Globulin Treatment in a Patient with Aplastic Anemia: A Case Report [PDF]

open access: yesJournal of Advanced Biomedical Sciences
is primarily managed through immunosuppression. Anti-thymocyte globulin (ATG), a polyclonal antibody derived from equine or lapine sources, is one such immunosuppressive treatment.
Mahdi Maleki Aghdam   +3 more
doaj  

Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up

open access: yes, 2012
Rabbit anti‐thymocyte globulin (rATG)–based immunosuppression induction is being increasingly used in liver transplantation (LT) in conjunction with steroid‐free protocols to delay the initiation of calcineurin inhibitors.
Paul Y. Kwo   +11 more
core   +1 more source

6-methylprednisolone does not impair anti-thymocyte globulin (ATG) immunosuppressive activity in non-human primates

open access: yes, 2001
Background: Induction treatments with anti-thymocyte globulin (ATG) in solid organ transplantation may enhance the efficacy of maintenance immunosuppressive therapy.
Beauchard, S   +6 more
core   +2 more sources

Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice

open access: yes, 2011
Lymphodepletion therapies are increasingly tested for controlling immune damage. One appealing premise for such a therapy is that it may 'reboot' the immune system and restore immune tolerance.
Maria Guillioli   +9 more
core   +1 more source

Acute Myeloid Leukemia Transformed from Aplastic Anemia following Anti-thymocyte Globulin Therapy: A Case Report with Clinicopathologic and Molecular Findings

open access: yes, 2022
: Aplastic Anemia (AA) incidence is threefold higher in Asia compared to the western world. It is associated with pancytopenia that is induced by impaired bone marrow function. Cytopenias of at least two lineages are required for the diagnosis.
Hassan, Jawad   +2 more
core  

Confusion and Agitation after a Recent Kidney Transplantation

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2008
A 51-year-old man, who received a living related transplant from his wife and anti-thymocyte globulin (ATG) as induction therapy, developed delayed graft function after transplantation. One day after he received an i.v.
Hussein Magdi   +3 more
doaj  

Home - About - Disclaimer - Privacy